UniProt ID | RPC5_HUMAN | |
---|---|---|
UniProt AC | Q9NVU0 | |
Protein Name | DNA-directed RNA polymerase III subunit RPC5 | |
Gene Name | POLR3E | |
Organism | Homo sapiens (Human). | |
Sequence Length | 708 | |
Subcellular Localization | Nucleus. | |
Protein Description | DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Specific peripheric component of RNA polymerase III which synthesizes small RNAs, such as 5S rRNA and tRNAs. Essential for efficient transcription from both the type 2 VAI and type 3 U6 RNA polymerase III promoters. Plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF- Kappa-B through the RIG-I pathway (By similarity).. | |
Protein Sequence | MANEEDDPVVQEIDVYLAKSLAEKLYLFQYPVRPASMTYDDIPHLSAKIKPKQQKVELEMAIDTLNPNYCRSKGEQIALNVDGACADETSTYSSKLMDKQTFCSSQTTSNTSRYAAALYRQGELHLTPLHGILQLRPSFSYLDKADAKHREREAANEAGDSSQDEAEDDVKQITVRFSRPESEQARQRRVQSYEFLQKKHAEEPWVHLHYYGLRDSRSEHERQYLLCPGSSGVENTELVKSPSEYLMMLMPPSQEEEKDKPVAPSNVLSMAQLRTLPLADQIKILMKNVKVMPFANLMSLLGPSIDSVAVLRGIQKVAMLVQGNWVVKSDILYPKDSSSPHSGVPAEVLCRGRDFVMWKFTQSRWVVRKEVATVTKLCAEDVKDFLEHMAVVRINKGWEFILPYDGEFIKKHPDVVQRQHMLWTGIQAKLEKVYNLVKETMPKKPDAQSGPAGLVCGDQRIQVAKTKAQQNHALLERELQRRKEQLRVPAVPPGVRIKEEPVSEEGEEDEEQEAEEEPMDTSPSGLHSKLANGLPLGRAAGTDSFNGHPPQGCASTPVARELKAFVEATFQRQFVLTLSELKRLFNLHLASLPPGHTLFSGISDRMLQDTVLAAGCKQILVPFPPQTAASPDEQKVFALWESGDMSDQHRQVLLEIFSKNYRVRRNMIQSRLTQECGEDLSKQEVDKVLKDCCVSYGGMWYLKGTVQS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
20 | Phosphorylation | IDVYLAKSLAEKLYL HHHHHHHHHHHHHHH | 27.49 | 22210691 | |
36 | Phosphorylation | QYPVRPASMTYDDIP CCCCCCCCCCCCCCC | 17.84 | 28348404 | |
38 | Phosphorylation | PVRPASMTYDDIPHL CCCCCCCCCCCCCCC | 22.70 | 28348404 | |
39 | Phosphorylation | VRPASMTYDDIPHLS CCCCCCCCCCCCCCC | 11.72 | 28122231 | |
64 | Phosphorylation | ELEMAIDTLNPNYCR HHEHHHHHCCHHHHC | 23.48 | 29759185 | |
69 | Phosphorylation | IDTLNPNYCRSKGEQ HHHCCHHHHCCCCCE | 7.18 | 29759185 | |
92 | Phosphorylation | CADETSTYSSKLMDK CCCCCCCCCCHHCCC | 15.66 | 30576142 | |
95 | Acetylation | ETSTYSSKLMDKQTF CCCCCCCHHCCCCCC | 41.72 | 30591449 | |
104 | Phosphorylation | MDKQTFCSSQTTSNT CCCCCCCCCCCCCCH | 22.68 | 30576142 | |
107 | Phosphorylation | QTFCSSQTTSNTSRY CCCCCCCCCCCHHHH | 33.85 | 25690035 | |
108 | Phosphorylation | TFCSSQTTSNTSRYA CCCCCCCCCCHHHHH | 16.61 | 30576142 | |
161 | Phosphorylation | AANEAGDSSQDEAED HHHHHCCCCHHHHHH | 29.05 | 29255136 | |
162 | Phosphorylation | ANEAGDSSQDEAEDD HHHHCCCCHHHHHHH | 46.52 | 29255136 | |
171 | Sumoylation | DEAEDDVKQITVRFS HHHHHHHHHHEEEEC | 42.87 | 28112733 | |
174 | Phosphorylation | EDDVKQITVRFSRPE HHHHHHHEEEECCCH | 11.79 | 28111955 | |
178 | Phosphorylation | KQITVRFSRPESEQA HHHEEEECCCHHHHH | 36.04 | 28509920 | |
182 | Phosphorylation | VRFSRPESEQARQRR EEECCCHHHHHHHHH | 37.38 | 28509920 | |
192 | Phosphorylation | ARQRRVQSYEFLQKK HHHHHHHHHHHHHHH | 24.63 | 23186163 | |
193 | Phosphorylation | RQRRVQSYEFLQKKH HHHHHHHHHHHHHHH | 8.13 | 23186163 | |
224 | Phosphorylation | RSEHERQYLLCPGSS CCHHHCEEEECCCCC | 14.09 | 22817900 | |
230 | Phosphorylation | QYLLCPGSSGVENTE EEEECCCCCCCCCCE | 14.73 | 28348404 | |
231 | Phosphorylation | YLLCPGSSGVENTEL EEECCCCCCCCCCEE | 53.42 | 28348404 | |
236 | Phosphorylation | GSSGVENTELVKSPS CCCCCCCCEECCCHH | 19.72 | 22817900 | |
241 | Phosphorylation | ENTELVKSPSEYLMM CCCEECCCHHHHHHH | 26.61 | 28348404 | |
243 | Phosphorylation | TELVKSPSEYLMMLM CEECCCHHHHHHHHC | 46.06 | 28348404 | |
245 | Phosphorylation | LVKSPSEYLMMLMPP ECCCHHHHHHHHCCC | 12.30 | 28348404 | |
287 | Ubiquitination | DQIKILMKNVKVMPF HHHHHHHHCCCEECH | 55.96 | - | |
376 | Ubiquitination | KEVATVTKLCAEDVK HHHHHHHHHHHHHHH | 36.91 | - | |
383 | Acetylation | KLCAEDVKDFLEHMA HHHHHHHHHHHHHCC | 55.90 | 20167786 | |
411 | Ubiquitination | YDGEFIKKHPDVVQR CCCHHHHHCCCHHHH | 56.40 | - | |
432 | Ubiquitination | GIQAKLEKVYNLVKE HHHHHHHHHHHHHHH | 61.53 | - | |
432 | Sumoylation | GIQAKLEKVYNLVKE HHHHHHHHHHHHHHH | 61.53 | 28112733 | |
434 | Phosphorylation | QAKLEKVYNLVKETM HHHHHHHHHHHHHHC | 17.53 | 30576142 | |
440 | Phosphorylation | VYNLVKETMPKKPDA HHHHHHHHCCCCCCC | 32.81 | 30576142 | |
443 | Ubiquitination | LVKETMPKKPDAQSG HHHHHCCCCCCCCCC | 67.14 | - | |
465 | Methylation | DQRIQVAKTKAQQNH CHHHHHHHHHHHHHH | 52.26 | 115975363 | |
467 | Ubiquitination | RIQVAKTKAQQNHAL HHHHHHHHHHHHHHH | 43.41 | - | |
467 | Methylation | RIQVAKTKAQQNHAL HHHHHHHHHHHHHHH | 43.41 | 115975371 | |
498 | Sumoylation | VPPGVRIKEEPVSEE CCCCCCCCCCCCCCC | 45.52 | 25114211 | |
498 | Sumoylation | VPPGVRIKEEPVSEE CCCCCCCCCCCCCCC | 45.52 | - | |
503 | Phosphorylation | RIKEEPVSEEGEEDE CCCCCCCCCCCCCHH | 40.42 | 23927012 | |
521 | Phosphorylation | AEEEPMDTSPSGLHS HHCCCCCCCCCHHHH | 35.96 | 23401153 | |
522 | Phosphorylation | EEEPMDTSPSGLHSK HCCCCCCCCCHHHHH | 16.89 | 30278072 | |
524 | Phosphorylation | EPMDTSPSGLHSKLA CCCCCCCCHHHHHHC | 54.47 | 23927012 | |
528 | Phosphorylation | TSPSGLHSKLANGLP CCCCHHHHHHCCCCC | 34.11 | 23927012 | |
544 | Phosphorylation | GRAAGTDSFNGHPPQ CCCCCCCCCCCCCCC | 22.05 | 21712546 | |
555 | Phosphorylation | HPPQGCASTPVAREL CCCCCCCCCHHHHHH | 37.00 | 25627689 | |
556 | Phosphorylation | PPQGCASTPVARELK CCCCCCCCHHHHHHH | 11.85 | 25627689 | |
603 | Phosphorylation | HTLFSGISDRMLQDT CCCCCCCCHHHHHHH | 23.77 | - | |
616 | Glutathionylation | DTVLAAGCKQILVPF HHHHHCCCCEEEEEC | 2.22 | 22555962 | |
653 (in isoform 2) | Phosphorylation | - | 2.41 | 26471730 | |
654 (in isoform 2) | Phosphorylation | - | 5.08 | 26471730 | |
658 | Phosphorylation | QVLLEIFSKNYRVRR HHHHHHHCCCHHHHH | 26.17 | 24719451 | |
659 (in isoform 2) | Phosphorylation | - | 47.45 | 26471730 | |
659 | Sumoylation | VLLEIFSKNYRVRRN HHHHHHCCCHHHHHH | 47.45 | 28112733 | |
659 | Sumoylation | VLLEIFSKNYRVRRN HHHHHHCCCHHHHHH | 47.45 | - | |
670 | Phosphorylation | VRRNMIQSRLTQECG HHHHHHHHHHHHHHC | 20.52 | 27067055 | |
673 | Phosphorylation | NMIQSRLTQECGEDL HHHHHHHHHHHCCCC | 22.63 | 27067055 | |
682 | Ubiquitination | ECGEDLSKQEVDKVL HHCCCCCHHHHHHHH | 58.75 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RPC5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RPC5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RPC5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161; SER-162; TYR-224AND SER-503, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161; SER-162; SER-503AND SER-522, AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY. |